Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02006381 · ClinicalTrials.gov registry record
Oxytocin Levels in Typically Developing Boys
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 60
- Enrollment target
NCT02006381: Completed study, sponsored by University of North Carolina, Chapel Hill.
NCT02006381 is a clinical trial that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02006381 has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
Measuring basal levels of plasma oxytocin in individuals with typical development across childhood and adolescence using both extracted and unextracted EIA methods.
Primary Outcome
20 children in each of 3 age cohorts 3-6, 7-12, and 13-17 will participate. Plasma oxytocin levels will be taken at the screening appointment.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2013-12 |
| Est. Completion | 2015-04 |
What the finished NCT02006381 record still lists
NCT02006381 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02006381 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02006381 about?
NCT02006381 is a clinical study titled "Oxytocin Levels in Typically Developing Boys". Measuring basal levels of plasma oxytocin in individuals with typical development across childhood and adolescence using both extracted and unextracted EIA methods.
What is the current status of trial NCT02006381?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2013-12. Estimated completion is 2015-04.
Who is sponsoring clinical trial NCT02006381?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia